| Website | regenemed.com |
| Category | BioTech |
| Phone | 858-200-9530 |
| info@regenemed.com | |
| Employees |
| TOTAL | $1M |
| FUNDING TOTAL | $1M |
| Venture Round, 1/07 Tech Coast Angels | $1M |
RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.
